Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-105054
Filing Date
2025-08-07
Accepted
2025-08-07 16:17:42
Documents
60
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rlay-20250630.htm   iXBRL 10-Q 2655460
2 EX-10.1 rlay-ex10_1.htm EX-10.1 24756
3 EX-10.2 rlay-ex10_2.htm EX-10.2 91986
4 EX-31.1 rlay-ex31_1.htm EX-31.1 18558
5 EX-31.2 rlay-ex31_2.htm EX-31.2 18377
6 EX-32.1 rlay-ex32_1.htm EX-32.1 17024
7 GRAPHIC img256780786_0.jpg GRAPHIC 176537
  Complete submission text file 0000950170-25-105054.txt   9727880

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rlay-20250630.xsd EX-101.SCH 1046533
62 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20250630_htm.xml XML 1822845
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39385 | Film No.: 251194314
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)